01/04/2026
𝐈𝐧𝐯𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬’ 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐟𝐨𝐫 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐀𝐮𝐭𝐡𝐨𝐫𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬
The Ethiopian Food and Drug Authority [EFDA] is committed to enhancing public health by improving access to safe, high-quality, and efficacious medicines. Over the past few years, EFDA has made significant strides in transforming the regulatory landscape to make it more efficient, transparent, and investor-friendly. One of our proudest achievements is attaining Maturity Level 3 (ML3) status from the World Health Organization’s Global Benchmarking Tool. This recognition affirms that EFDA operates as a stable, well-functioning, and integrated regulatory system, aligned with international best practices. We have implemented substantial improvements in timeline management for medicine registration through process optimizations and dedicated resources, ensuring faster reviews without compromising quality.
To support manufacturers in navigating the regulatory landscape, and to streamline the approval process for Health products, we are hosting an exclusive webinar.
The objective of this session is to provide direct insights into the Country’s regulatory requirements, address common pitfalls (bottlenecks) in dossier submission, and accelerate the Marketing Authorization process.
𝘞𝘦𝘣𝘪𝘯𝘢𝘳 𝘋𝘦𝘵𝘢𝘪𝘭𝘴:
𝘛𝘰𝘱𝘪𝘤: 𝘚𝘵𝘳𝘢𝘵𝘦𝘨𝘪𝘦𝘴 𝘧𝘰𝘳 𝘚𝘶𝘤𝘤𝘦𝘴𝘴𝘧𝘶𝘭 𝘔𝘢𝘳𝘬𝘦𝘵𝘪𝘯𝘨 𝘈𝘶𝘵𝘩𝘰𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴
𝘋𝘢𝘵𝘦: [𝘈𝘱𝘳𝘪𝘭 16, 2026]
𝘛𝘪𝘮𝘦 𝘪𝘯 𝘩𝘰𝘴𝘵 𝘤𝘰𝘶𝘯𝘵𝘳𝘺 (𝘌𝘵𝘩𝘪𝘰𝘱𝘪𝘢): 𝘧𝘳𝘰𝘮 11:00 𝘈.𝘔. 𝘵𝘰 3:30 𝘱𝘮 & 𝘐𝘯𝘥𝘪𝘢 𝘵𝘪𝘮𝘦 𝘧𝘳𝘰𝘮 1:30𝘱𝘮 𝘵𝘰 5:30 𝘱𝘮
𝘗𝘭𝘢𝘵𝘧𝘰𝘳𝘮: 𝘡𝘰𝘰𝘮
RegistrationLink: https://r4d-org.zoom.us/webinar/register/WN_P6QDmvsqT4GsPit_cV5xTg
𝐀𝐠𝐞𝐧𝐝𝐚 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:
Regulatory Updates: Overview of Regulatory Requirements for Health Product Dossier submission.
EFDA Strategey for Streamlining Dossier Approval: Strategy for expidite Marketing Authorization of essential medicine.
Market Access Opportunities: Insights into essential medicine needs.
Live Q&A Session: Direct interaction with regulatory reviewers.
We strongly encourage all Marketing Authorization Holders, Indian Drug Manufacturers` Association (IDMA), Manufacturers and your Regulatory Affairs team to participate to ensure your submissions is "regulator-ready," minimizing clock-stops and approval delays.
𝘍𝘰𝘳 𝘢𝘯𝘺 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯, 𝘱𝘭𝘦𝘢𝘴𝘦 𝘤𝘰𝘯𝘵𝘢𝘤𝘵: 𝘔𝘦𝘯𝘨𝘪𝘴𝘵𝘶 𝘓𝘦𝘨𝘦𝘴𝘴𝘦: 𝘮𝘭𝘦𝘨𝘦𝘴𝘴𝘦@𝘦𝘧𝘥𝘢.𝘨𝘰𝘷.𝘦𝘵 +251912105691, 𝘍𝘢𝘴𝘪𝘭 𝘏𝘢𝘪𝘭𝘦𝘮𝘢𝘳𝘪𝘢𝘮: 𝘧𝘩𝘢𝘪𝘭𝘦𝘮𝘢𝘳𝘪𝘢𝘮@𝘦𝘧𝘥𝘢.𝘨𝘰𝘷.𝘦𝘵, +251911950615, 𝘋𝘢𝘯𝘪𝘦𝘭 𝘛𝘢𝘬𝘦𝘭: 𝘥𝘵𝘢𝘬𝘦𝘭𝘦@𝘦𝘧𝘥𝘢.𝘨𝘰𝘷.𝘦𝘵, +251923145480, 𝘢𝘯𝘥 𝘛𝘩𝘦𝘰𝘥𝘳𝘰𝘴 𝘍𝘦𝘯𝘵𝘢: 𝘵𝘧𝘦𝘯𝘵𝘢@𝘦𝘧𝘥𝘢.𝘨𝘰𝘷.𝘦𝘵, +251911150099
